Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.84 USD | -1.32% | +11.49% | 0.00% |
May. 16 | ArriVent BioPharma, Inc. Appoints John Hohneker as Board of Directors | CI |
May. 08 | ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- AVBP Stock
- Revisions ArriVent BioPharma, Inc.